Analysis of loco-regional failures in head and neck cancer after radical radiation therapy

Oral Oncology

Volumn 51, Issue 11, 2015, Pages 1051-1055

  De Felice, Francesca ^a,b   Thomas, Christopher ^a   Barrington, Sally ^c   Pathmanathan, Angela ^a   Lei, Mary ^a   Urbano, Teresa Guerrero ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

CTV; Head and neck cancer; IMRT; Loco regional failure; Persistence; Radiation; Radical; Radiotherapy; Recurrence; Volumetric

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TARGET VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; DOSIMETRY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LARYNX SQUAMOUS CELL CARCINOMA; LOADING DRUG DOSE; LOCO REGIONAL TREATMENT FAILURE; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR VOLUME; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; MIDDLE AGED; PROCEDURES; RADIOTHERAPY DOSAGE; RISK FACTOR; SALVAGE THERAPY; STATISTICS AND NUMERICAL DATA; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS; SALVAGE THERAPY; TREATMENT FAILURE; TUMOR BURDEN;

EID: 84944719506     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.08.004     Document Type: Article

References (23)

1. National Comprehensive Cancer Network Guidelines Head and Neck Version 2.2014. http://www.nccn.org/.
2. A.K. Due, I.R. Vogelius, M.C. Aznar, S.M. Bentzen, A.K. Berthelsen, S.S. Korreman, and et al. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake Radiother Oncol 111 3 2014 360 365 10.1016/j.radonc.2014.06.001
3. E. Bayman, R.J. Prestwich, R. Speight, L. Aspin, L. Garratt, S. Wilson, and et al. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation Clin Oncol (R Coll Radiol) 26 10 2014 636 642
4. J. Bourhis, J. Overgaard, H. Audry, K.K. Ang, M. Saunders, J. Bernier, and et al. Meta-analysis of radiotherapy in carcinomas of head and neck (MARCH) collaborative group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 9538 2006 843 854
5. J.P. Pignon, A. le Maître, E. Maillard, and J. Bourhis MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 1 2009 4 14
6. A. Jackson, L.B. Marks, S.M. Bentzen, A. Eisbruch, E.D. Yorke, R.K. Ten Haken, and et al. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S155 S160
7. F.L. Green, C.C. Compton, A.G. Fritz, J. Shah, and D.P. Winchester AJCC cancer staging atlas 6th ed. 2007 Springer New York
8. V. Grégoire, P. Levendag, K.K. Ang, J. Bernier, M. Braaksma, V. Budach, and et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines Radiother Oncol 69 3 2003 Dec 227 236
9. V. Grégoire, K. Ang, W. Budach, C. Grau, M. Hamoir, J.A. Langendijk, and et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines Radiother Oncol 110 1 2014 Jan 172 181
10. V. Grégoire, A. Eisbruch, M. Hamoir, and P. Levendag Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck Radiother Oncol 79 1 2006 Apr 15 20
11. Lok BH, Setton J, Ho F, Riaz N, Rao SS, Lee NY. Nasopharynx. In: Halperin EC, Brady LW, Perez CA, Wazer DE. Perez & Brady's principles and practice of radiation oncology. 6th ed., vol. 41. p. 730-59.
12. L.A. Dawson, Y. Anzai, L. Marsh, M.K. Martel, A. Paulino, J.A. Ship, and et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 46 5 2000 Mar 15 1117 1126
13. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 4 1996 343 346
14. A.S. Garden, L. Dong, W.H. Morrison, E.M. Stugis, B.S. Glisson, S.J. Frank, and et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy Int J Radiat Oncol Biol Phys 85 4 2013 941 947
15. K.S. Chao, G. Ozyigit, B.N. Tran, M. Cengiz, J.F. Dempsey, and D.A. Low Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer Int J Radiat Oncol Biol Phys 55 2 2003 312 321
16. G. Studer, U.M. Luetolf, and C. Glanzmann Locoregional failure analysis in head-and-neck cancer patients treated with IMRT Strahlenther Onkol 183 8 2007 417 423 [discussion 424-5]
17. A. Eisbruch, L.H. Marsh, L.A. Dawson, C.R. Bradford, T.N. Teknos, D.B. Chepeha, and et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing Int J Radiat Oncol Biol Phys 59 1 2004 28 42
18. M. Yao, K.J. Dornfeld, J.M. Buatti, M. Skwarchuk, H. Tan, T. Nguyen, and et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience Int J Radiat Oncol Biol Phys 63 2 2005 410 421
19. Lok BH, Setton J, Ho F, Riaz N, Rao SS, Lee N. Nasopharynx. In: Perez and Brady's Principles and Practice of Radiation Oncology. p. 732-35.
20. A. Eisbruch, and V. Gregoire Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer Semin Radiat Oncol 19 1 2009 Jan 43 52
21. C.M. Nutting, J.P. Morden, K.J. Harrington, T.G. Urbano, S.A. Bhide, C. Clark, and et al. Hall E; PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2 2011 Feb 127 136
22. F.Y. Feng, H.M. Kim, T.H. Lyden, M.J. Haxer, F.P. Worden, M. Feng, and et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results J Clin Oncol 28 16 2010 Jun 1 2732 2738
23. S.A. Bhide, S. Gulliford, R. Kazi, I. El-Hariry, K. Newbold, K.J. Harrington, and et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer Radiother Oncol 93 3 2009 539 544